This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all aspects of benign and malignant lesions of lymph nodes and extranodal and splenic lymphomas, it incorporates the most recent clinical, pathological, and molecular knowledge in this challenging field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas, third edition, is a one-stop reference for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable training resource.
Presents concise, extensive, and up-to-date information on more than 120 benign and malignant lesions of the lymph nodes, and covers extranodal lymphomas to help new and experienced surgical pathologists and hematopathologists alike identify crucial elements of each diagnosis and associated differential diagnoses
Provides clinical and histologic features, results of relevant ancillary studies, and a differential diagnosis for each entry
Features extensive updates throughout, reflecting the increasing importance of molecular markers for more precise diagnoses, and covering newly defined disease entities
Includes new chapters covering EBV( ) T- and NK-cell lymphoproliferative disorders of childhood, Erdheim-Chester disease, indolent T-cell lymphoproliferative disorder of the gastrointestinal tract, primary cutaneous acral CD8( ) lymphoma, primary cutaneous CD4( ) small/medium T-cell lymphoproliferative disorder, and primary cutaneous CD8( ) aggressive epidermotropic cytotoxic T-cell lymphoma; also provides new information on breast implant-associated anaplastic large cell lymphoma
Contains more than 3,400 high-quality clinical and histological images, gross pathology images, radiologic images, micrographs, flow cytometry histograms, and full-color illustrations to help practicing and in-training pathologists reach a confident diagnosis
Includes updated criteria, terminology, and classifications using the WHO Classification of Hematolymphoid Tumors: Lymphoid Neoplasms, 5th edition
Employs consistently templated chapters, bulleted content, key facts, a variety of test data tables, annotated images, and an extensive index for quick, expert reference at the point of care
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedications - p. iii 6. Preface - p. v 7. Acknowledgments - p. vii 8. Sections - p. vii 9. SECTION 1: REACTIVE NONSPECIFIC CHANGES - p. vii 10. List of Tables - p. vii 11. Chapter 1: Reactive Follicular Hyperplasia - p. vii 12. Chapter 2: Reactive Paracortical Hyperplasia - p. 9 13. SECTION 2: INFECTIOUS CAUSES OF LYMPHADENITIS - p. 17 14. Chapter 3: Chronic Granulomatous Lymphadenitis - p. 17 15. Chapter 4: Suppurative Lymphadenitis - p. 27 16. Chapter 5: Mycobacterium tuberculosis Lymphadenitis - p. 31 17. Chapter 6: Atypical Mycobacterial Lymphadenitis - p. 39 18. Chapter 7: Mycobacterial Spindle Cell Pseudotumor - p. 47 19. Chapter 8: Cat-Scratch Disease - p. 51 20. Chapter 9: Bacillary Angiomatosis - p. 57 21. Chapter 10: Lymphogranuloma Venereum Lymphadenitis - p. 63 22. Chapter 11: Whipple Disease - p. 67 23. Chapter 12: Syphilitic Lymphadenitis - p. 71 24. Chapter 13: Infectious Mononucleosis - p. 77 25. Chapter 14: Histoplasma Lymphadenitis - p. 83 26. Chapter 15: Cryptococcus Lymphadenitis - p. 89 27. Chapter 16: Toxoplasma Lymphadenitis - p. 93 28. Chapter 17: Coccidioides Lymphadenitis - p. 99 29. Chapter 18: Herpes Simplex Lymphadenitis - p. 105 30. Chapter 19: Cytomegalovirus Lymphadenitis - p. 111 31. Chapter 20: Human Immunodeficiency Virus Lymphadenitis - p. 119 32. SECTION 3: REACTIVE LYMPHADENOPATHIES - p. 129 33. Chapter 21: Inflammatory Pseudotumor of Lymph Node - p. 129 34. Chapter 22: Progressive Transformation of Germinal Centers - p. 139 35. Chapter 23: Kikuchi-Fujimoto Disease - p. 145 36. Chapter 24: Rosai-Dorfman Disease - p. 155 37. Chapter 25: Kimura Disease - p. 165 38. Chapter 26: Unicentric Hyaline-Vascular Variant Castleman Disease - p. 173 39. Chapter 27: Unicentric Mixed/Plasmacytic Variant Castleman Disease - p. 181 40. Chapter 28: Multicentric Castleman Disease, Idiopathic - p. 187 41. Chapter 29: Multicentric Castleman Disease, HHV8 Associated - p. 195 42. Chapter 30: Rheumatoid Arthritis-Related Lymphadenopathy - p. 203 43. Chapter 31: Sarcoid Lymphadenopathy - p. 211 44. Chapter 32: Dermatopathic Lymphadenopathy - p. 217 45. Chapter 33: Hemophagocytic Lymphohistiocytosis - p. 223 46. Chapter 34: Lymphadenopathy Associated With Joint Prostheses - p. 233 47. Chapter 35: Lipid-Associated Lymphadenopathy - p. 239 48. Chapter 36: Lymphadenopathy Secondary to Drug-Induced Hypersensitivity Syndrome - p. 243 49. Chapter 37: IgG4-Related Disease - p. 253 50. Chapter 38: Systemic Lupus Erythematosus - p. 263 51. Chapter 39: Sinus Histiocytosis - p. 269 52. SECTION 4: HODGKIN LYMPHOMAS - p. 275 53. Chapter 40: Nodular Lymphocyte-Predominant Hodgkin Lymphoma - p. 275 54. Chapter 41: Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Tables - p. 289 55. Chapter 42: Lymphocyte-Rich Classic Hodgkin Lymphoma - p. 291 56. Chapter 43: Nodular Sclerosis Hodgkin Lymphoma - p. 299 57. Chapter 44: Mixed Cellularity Hodgkin Lymphoma - p. 309 58. Chapter 45: Lymphocyte-Depleted Hodgkin Lymphoma - p. 315 59. SECTION 5: LEUKEMIA/LYMPHOMAS OF IMMATURE B- OR T-CELL LINEAGE - p. 321 60. Chapter 46: B-Lymphoblastic Leukemia/Lymphoma - p. 321 61. Chapter 47: T-Lymphoblastic Lymphoma/Leukemia - p. 333 62. SECTION 6: NODAL B-CELL LYMPHOMAS - p. 343 63. Chapter 48: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - p. 343 64. Chapter 49: Richter Transformation - p. 355 65. Chapter 50: Lymphoplasmacytic Lymphoma and Waldenström Macroglobulinemia - p. 363 66. Chapter 51: Nodal Marginal Zone Lymphoma - p. 373 67. Chapter 52: Nodal Follicular Lymphoma - p. 379 68. Chapter 53: Pediatric-Type Follicular Lymphoma - p. 391 69. Chapter 54: Mantle Cell Lymphoma - p. 395 70. Chapter 55: Mantle Cell Lymphoma, Blastoid and Pleomorphic Variants - p. 403 71. Chapter 56: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified - p. 411 72. Chapter 57: T-Cell/Histiocyte-Rich Large B-Cell Lymphoma - p. 421 73. Chapter 58: ALK(+) Large B-Cell Lymphoma - p. 427 74. Chapter 59: EBV(+) Diffuse Large B-Cell Lymphoma - p. 433 75. Chapter 60: HHV8(+) Diffuse Large B-Cell Lymphoma - p. 441 76. Chapter 61: Burkitt Lymphoma - p. 449 77. Chapter 62: High-Grade B-Cell Lymphoma - p. 459 78. Chapter 63: Mediastinal Gray Zone Lymphoma - p. 467 79. SECTION 7: EXTRANODAL B-CELL LYMPHOMAS - p. 477 80. Chapter 64: Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) - p. 477 81. Chapter 65: Extranodal Follicular Lymphoma - p. 493 82. Chapter 66: Primary Cutaneous Follicle Center Lymphoma - p. 505 83. Chapter 67: Primary Mediastinal (Thymic) Large B-Cell Lymphoma - p. 515 84. Chapter 68: Primary Diffuse Large B-Cell Lymphoma of Central Nervous System - p. 525 85. Chapter 69: Pyothorax-Associated Lymphoma - p. 535 86. Chapter 70: Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type - p. 541 87. Chapter 71: Plasmablastic Lymphoma - p. 549 88. Chapter 72: Primary Effusion Lymphoma and Solid Variant of Primary Effusion Lymphoma - p. 559 89. Chapter 73: Lymphomatoid Granulomatosis - p. 569 90. Chapter 74: Intravascular Large B-Cell Lymphoma - p. 579 91. Chapter 75: Plasmacytoma - p. 585 92. Chapter 76: EBV-Positive Large B-Cell Lymphoma Associated With Breast Implants - p. 593 93. Chapter 77: Primary Diffuse Large B-Cell Lymphoma of Testis - p. 599 94. Chapter 78: Splenic Marginal Zone Lymphoma - p. 607 95. Chapter 79: Hairy Cell Leukemia - p. 615 96. Chapter 80: Hairy Cell Leukemia Variant - p. 623 97. Chapter 81: Splenic Diffuse Red Pulp B-Cell Lymphoma - p. 631 98. Chapter 82: Diffuse Large B-Cell Lymphoma Arising in the Spleen - p. 637 99. SECTION 8: NODAL T-CELL LYMPHOMAS - p. 643 100. Chapter 83: Peripheral T-Cell Lymphoma, Not Otherwise Specified - p. 643 101. Chapter 84: Angioimmunoblastic T-Cell Lymphoma - p. 655 102. Chapter 85: Adult T-Cell Leukemia/Lymphoma, HTLV-1(+) - p. 665 103. Chapter 86: ALK(+) Anaplastic Large Cell Lymphoma - p. 675 104. Chapter 87: ALK(-) Anaplastic Large Cell Lymphoma - p. 683 105. SECTION 9: EXTRANODAL NK-/T-CELL LYMPHOMAS - p. 691 106. Chapter 88: Breast Implant-Associated Anaplastic Large Cell Lymphoma - p. 691 107. Chapter 89: Extranodal NK-/T-Cell Lymphoma - p. 705 108. Chapter 90: Hepatosplenic T-Cell Lymphoma - p. 715 109. Chapter 91: Enteropathy-Associated T-Cell Lymphoma - p. 725 110. Chapter 92: Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma - p. 733 111. Chapter 93: Indolent T-Cell Lymphoma of the Gastrointestinal Tract - p. 741 112. Chapter 94: Subcutaneous Panniculitis-Like T-Cell Lymphoma - p. 747 113. Chapter 95: T-Cell Prolymphocytic Leukemia Involving Lymph Node and Other Tissues - p. 755 114. Chapter 96: Primary Cutaneous γ/δ T-Cell Lymphoma - p. 765 115. Chapter 97: EBV(+) T- and NK-Cell Lymphoid Proliferations and Lymphomas of Childhood - p. 773 116. Chapter 98: Mycosis Fungoides - p. 783 117. Chapter 99: Sézary Syndrome - p. 797 118. Chapter 100: Primary Cutaneous Anaplastic Large Cell Lymphoma - p. 809 119. Chapter 101: Lymphomatoid Papulosis - p. 817 120. Chapter 102: Primary Cutaneous Acral CD8(+) Lymphoproliferative Disorder - p. 825 121. Chapter 103: Primary Cutaneous CD8(+) Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma - p. 831 122. Chapter 104: Primary Cutaneous CD4(+) Small/Medium T-Cell Lymphoproliferative Disorder - p. 839 123. SECTION 10: IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIONS - p. 843 124. Chapter 105: Overview of Primary Immunodeficiency-Associated Lymphoproliferative Disorders - p. 843 125. Chapter 106: Autoimmune Lymphoproliferative Syndrome - p. 851 126. Chapter 107: Immunomodulating Agent-Associated Lymphoproliferative Disorders - p. 863 127. Chapter 108: Posttransplant Lymphoproliferative Disorders, Nondestructive Lesions and Polymorphic - p. 871 128. Chapter 109: Posttransplant Lymphoproliferative Disorder, Monomorphic - p. 881 129. Chapter 110: EBV(+) Mucocutaneous Ulcer - p. 891 130. SECTION 11: GRANULOCYTIC/HISTIOCYTIC TUMORS - p. 895 131. Chapter 111: Myeloid Sarcoma - p. 895 132. Chapter 112: Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 905 133. Chapter 113: Blastic T/Myeloid Neoplasm With Rearrangements of FGFR1 - p. 913 134. Chapter 114: Cutaneous Mastocytosis - p. 923 135. Chapter 115: Systemic Mastocytosis - p. 927 136. Chapter 116: Histiocytic Sarcoma - p. 939 137. Chapter 117: Follicular Dendritic Cell Sarcoma - p. 949 138. Chapter 118: Interdigitating Dendritic Cell Sarcoma - p. 957 139. Chapter 119: Langerhans Cell Histiocytosis - p. 963 140. Chapter 120: Langerhans Cell Sarcoma - p. 975 141. Chapter 121: Erdheim-Chester Disease - p. 983 142. SECTION 12: NONHEMATOPOIETIC PROLIFERATIONS IN LYMPH NODE - p. 987 143. Chapter 122: Epithelial Inclusions in Lymph Node - p. 987 144. Chapter 123: Nevus Cell Inclusions in Lymph Node - p. 995 145. Chapter 124: Vascular Transformation of Lymph Node Sinuses - p. 999 146. Chapter 125: Angiomyomatous Hamartoma - p. 1003 147. Chapter 126: Palisaded Myofibroblastoma - p. 1007 148. Chapter 127: Metastatic Kaposi Sarcoma - p. 1011 149. INDEX - p. 1017
This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all aspects of benign and malignant lesions of lymph nodes and extranodal and splenic lymphomas, it incorporates the most recent clinical, pathological, and molecular knowledge in this challenging field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas, third edition, is a one-stop reference for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable training resource.
Presents concise, extensive, and up-to-date information on more than 120 benign and malignant lesions of the lymph nodes, and covers extranodal lymphomas to help new and experienced surgical pathologists and hematopathologists alike identify crucial elements of each diagnosis and associated differential diagnoses
Provides clinical and histologic features, results of relevant ancillary studies, and a differential diagnosis for each entry
Features extensive updates throughout, reflecting the increasing importance of molecular markers for more precise diagnoses, and covering newly defined disease entities
Includes new chapters covering EBV( ) T- and NK-cell lymphoproliferative disorders of childhood, Erdheim-Chester disease, indolent T-cell lymphoproliferative disorder of the gastrointestinal tract, primary cutaneous acral CD8( ) lymphoma, primary cutaneous CD4( ) small/medium T-cell lymphoproliferative disorder, and primary cutaneous CD8( ) aggressive epidermotropic cytotoxic T-cell lymphoma; also provides new information on breast implant-associated anaplastic large cell lymphoma
Contains more than 3,400 high-quality clinical and histological images, gross pathology images, radiologic images, micrographs, flow cytometry histograms, and full-color illustrations to help practicing and in-training pathologists reach a confident diagnosis
Includes updated criteria, terminology, and classifications using the WHO Classification of Hematolymphoid Tumors: Lymphoid Neoplasms, 5th edition
Employs consistently templated chapters, bulleted content, key facts, a variety of test data tables, annotated images, and an extensive index for quick, expert reference at the point of care
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedications - p. iii 6. Preface - p. v 7. Acknowledgments - p. vii 8. Sections - p. vii 9. SECTION 1: REACTIVE NONSPECIFIC CHANGES - p. vii 10. List of Tables - p. vii 11. Chapter 1: Reactive Follicular Hyperplasia - p. vii 12. Chapter 2: Reactive Paracortical Hyperplasia - p. 9 13. SECTION 2: INFECTIOUS CAUSES OF LYMPHADENITIS - p. 17 14. Chapter 3: Chronic Granulomatous Lymphadenitis - p. 17 15. Chapter 4: Suppurative Lymphadenitis - p. 27 16. Chapter 5: Mycobacterium tuberculosis Lymphadenitis - p. 31 17. Chapter 6: Atypical Mycobacterial Lymphadenitis - p. 39 18. Chapter 7: Mycobacterial Spindle Cell Pseudotumor - p. 47 19. Chapter 8: Cat-Scratch Disease - p. 51 20. Chapter 9: Bacillary Angiomatosis - p. 57 21. Chapter 10: Lymphogranuloma Venereum Lymphadenitis - p. 63 22. Chapter 11: Whipple Disease - p. 67 23. Chapter 12: Syphilitic Lymphadenitis - p. 71 24. Chapter 13: Infectious Mononucleosis - p. 77 25. Chapter 14: Histoplasma Lymphadenitis - p. 83 26. Chapter 15: Cryptococcus Lymphadenitis - p. 89 27. Chapter 16: Toxoplasma Lymphadenitis - p. 93 28. Chapter 17: Coccidioides Lymphadenitis - p. 99 29. Chapter 18: Herpes Simplex Lymphadenitis - p. 105 30. Chapter 19: Cytomegalovirus Lymphadenitis - p. 111 31. Chapter 20: Human Immunodeficiency Virus Lymphadenitis - p. 119 32. SECTION 3: REACTIVE LYMPHADENOPATHIES - p. 129 33. Chapter 21: Inflammatory Pseudotumor of Lymph Node - p. 129 34. Chapter 22: Progressive Transformation of Germinal Centers - p. 139 35. Chapter 23: Kikuchi-Fujimoto Disease - p. 145 36. Chapter 24: Rosai-Dorfman Disease - p. 155 37. Chapter 25: Kimura Disease - p. 165 38. Chapter 26: Unicentric Hyaline-Vascular Variant Castleman Disease - p. 173 39. Chapter 27: Unicentric Mixed/Plasmacytic Variant Castleman Disease - p. 181 40. Chapter 28: Multicentric Castleman Disease, Idiopathic - p. 187 41. Chapter 29: Multicentric Castleman Disease, HHV8 Associated - p. 195 42. Chapter 30: Rheumatoid Arthritis-Related Lymphadenopathy - p. 203 43. Chapter 31: Sarcoid Lymphadenopathy - p. 211 44. Chapter 32: Dermatopathic Lymphadenopathy - p. 217 45. Chapter 33: Hemophagocytic Lymphohistiocytosis - p. 223 46. Chapter 34: Lymphadenopathy Associated With Joint Prostheses - p. 233 47. Chapter 35: Lipid-Associated Lymphadenopathy - p. 239 48. Chapter 36: Lymphadenopathy Secondary to Drug-Induced Hypersensitivity Syndrome - p. 243 49. Chapter 37: IgG4-Related Disease - p. 253 50. Chapter 38: Systemic Lupus Erythematosus - p. 263 51. Chapter 39: Sinus Histiocytosis - p. 269 52. SECTION 4: HODGKIN LYMPHOMAS - p. 275 53. Chapter 40: Nodular Lymphocyte-Predominant Hodgkin Lymphoma - p. 275 54. Chapter 41: Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Tables - p. 289 55. Chapter 42: Lymphocyte-Rich Classic Hodgkin Lymphoma - p. 291 56. Chapter 43: Nodular Sclerosis Hodgkin Lymphoma - p. 299 57. Chapter 44: Mixed Cellularity Hodgkin Lymphoma - p. 309 58. Chapter 45: Lymphocyte-Depleted Hodgkin Lymphoma - p. 315 59. SECTION 5: LEUKEMIA/LYMPHOMAS OF IMMATURE B- OR T-CELL LINEAGE - p. 321 60. Chapter 46: B-Lymphoblastic Leukemia/Lymphoma - p. 321 61. Chapter 47: T-Lymphoblastic Lymphoma/Leukemia - p. 333 62. SECTION 6: NODAL B-CELL LYMPHOMAS - p. 343 63. Chapter 48: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - p. 343 64. Chapter 49: Richter Transformation - p. 355 65. Chapter 50: Lymphoplasmacytic Lymphoma and Waldenström Macroglobulinemia - p. 363 66. Chapter 51: Nodal Marginal Zone Lymphoma - p. 373 67. Chapter 52: Nodal Follicular Lymphoma - p. 379 68. Chapter 53: Pediatric-Type Follicular Lymphoma - p. 391 69. Chapter 54: Mantle Cell Lymphoma - p. 395 70. Chapter 55: Mantle Cell Lymphoma, Blastoid and Pleomorphic Variants - p. 403 71. Chapter 56: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified - p. 411 72. Chapter 57: T-Cell/Histiocyte-Rich Large B-Cell Lymphoma - p. 421 73. Chapter 58: ALK(+) Large B-Cell Lymphoma - p. 427 74. Chapter 59: EBV(+) Diffuse Large B-Cell Lymphoma - p. 433 75. Chapter 60: HHV8(+) Diffuse Large B-Cell Lymphoma - p. 441 76. Chapter 61: Burkitt Lymphoma - p. 449 77. Chapter 62: High-Grade B-Cell Lymphoma - p. 459 78. Chapter 63: Mediastinal Gray Zone Lymphoma - p. 467 79. SECTION 7: EXTRANODAL B-CELL LYMPHOMAS - p. 477 80. Chapter 64: Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) - p. 477 81. Chapter 65: Extranodal Follicular Lymphoma - p. 493 82. Chapter 66: Primary Cutaneous Follicle Center Lymphoma - p. 505 83. Chapter 67: Primary Mediastinal (Thymic) Large B-Cell Lymphoma - p. 515 84. Chapter 68: Primary Diffuse Large B-Cell Lymphoma of Central Nervous System - p. 525 85. Chapter 69: Pyothorax-Associated Lymphoma - p. 535 86. Chapter 70: Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type - p. 541 87. Chapter 71: Plasmablastic Lymphoma - p. 549 88. Chapter 72: Primary Effusion Lymphoma and Solid Variant of Primary Effusion Lymphoma - p. 559 89. Chapter 73: Lymphomatoid Granulomatosis - p. 569 90. Chapter 74: Intravascular Large B-Cell Lymphoma - p. 579 91. Chapter 75: Plasmacytoma - p. 585 92. Chapter 76: EBV-Positive Large B-Cell Lymphoma Associated With Breast Implants - p. 593 93. Chapter 77: Primary Diffuse Large B-Cell Lymphoma of Testis - p. 599 94. Chapter 78: Splenic Marginal Zone Lymphoma - p. 607 95. Chapter 79: Hairy Cell Leukemia - p. 615 96. Chapter 80: Hairy Cell Leukemia Variant - p. 623 97. Chapter 81: Splenic Diffuse Red Pulp B-Cell Lymphoma - p. 631 98. Chapter 82: Diffuse Large B-Cell Lymphoma Arising in the Spleen - p. 637 99. SECTION 8: NODAL T-CELL LYMPHOMAS - p. 643 100. Chapter 83: Peripheral T-Cell Lymphoma, Not Otherwise Specified - p. 643 101. Chapter 84: Angioimmunoblastic T-Cell Lymphoma - p. 655 102. Chapter 85: Adult T-Cell Leukemia/Lymphoma, HTLV-1(+) - p. 665 103. Chapter 86: ALK(+) Anaplastic Large Cell Lymphoma - p. 675 104. Chapter 87: ALK(-) Anaplastic Large Cell Lymphoma - p. 683 105. SECTION 9: EXTRANODAL NK-/T-CELL LYMPHOMAS - p. 691 106. Chapter 88: Breast Implant-Associated Anaplastic Large Cell Lymphoma - p. 691 107. Chapter 89: Extranodal NK-/T-Cell Lymphoma - p. 705 108. Chapter 90: Hepatosplenic T-Cell Lymphoma - p. 715 109. Chapter 91: Enteropathy-Associated T-Cell Lymphoma - p. 725 110. Chapter 92: Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma - p. 733 111. Chapter 93: Indolent T-Cell Lymphoma of the Gastrointestinal Tract - p. 741 112. Chapter 94: Subcutaneous Panniculitis-Like T-Cell Lymphoma - p. 747 113. Chapter 95: T-Cell Prolymphocytic Leukemia Involving Lymph Node and Other Tissues - p. 755 114. Chapter 96: Primary Cutaneous γ/δ T-Cell Lymphoma - p. 765 115. Chapter 97: EBV(+) T- and NK-Cell Lymphoid Proliferations and Lymphomas of Childhood - p. 773 116. Chapter 98: Mycosis Fungoides - p. 783 117. Chapter 99: Sézary Syndrome - p. 797 118. Chapter 100: Primary Cutaneous Anaplastic Large Cell Lymphoma - p. 809 119. Chapter 101: Lymphomatoid Papulosis - p. 817 120. Chapter 102: Primary Cutaneous Acral CD8(+) Lymphoproliferative Disorder - p. 825 121. Chapter 103: Primary Cutaneous CD8(+) Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma - p. 831 122. Chapter 104: Primary Cutaneous CD4(+) Small/Medium T-Cell Lymphoproliferative Disorder - p. 839 123. SECTION 10: IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIONS - p. 843 124. Chapter 105: Overview of Primary Immunodeficiency-Associated Lymphoproliferative Disorders - p. 843 125. Chapter 106: Autoimmune Lymphoproliferative Syndrome - p. 851 126. Chapter 107: Immunomodulating Agent-Associated Lymphoproliferative Disorders - p. 863 127. Chapter 108: Posttransplant Lymphoproliferative Disorders, Nondestructive Lesions and Polymorphic - p. 871 128. Chapter 109: Posttransplant Lymphoproliferative Disorder, Monomorphic - p. 881 129. Chapter 110: EBV(+) Mucocutaneous Ulcer - p. 891 130. SECTION 11: GRANULOCYTIC/HISTIOCYTIC TUMORS - p. 895 131. Chapter 111: Myeloid Sarcoma - p. 895 132. Chapter 112: Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 905 133. Chapter 113: Blastic T/Myeloid Neoplasm With Rearrangements of FGFR1 - p. 913 134. Chapter 114: Cutaneous Mastocytosis - p. 923 135. Chapter 115: Systemic Mastocytosis - p. 927 136. Chapter 116: Histiocytic Sarcoma - p. 939 137. Chapter 117: Follicular Dendritic Cell Sarcoma - p. 949 138. Chapter 118: Interdigitating Dendritic Cell Sarcoma - p. 957 139. Chapter 119: Langerhans Cell Histiocytosis - p. 963 140. Chapter 120: Langerhans Cell Sarcoma - p. 975 141. Chapter 121: Erdheim-Chester Disease - p. 983 142. SECTION 12: NONHEMATOPOIETIC PROLIFERATIONS IN LYMPH NODE - p. 987 143. Chapter 122: Epithelial Inclusions in Lymph Node - p. 987 144. Chapter 123: Nevus Cell Inclusions in Lymph Node - p. 995 145. Chapter 124: Vascular Transformation of Lymph Node Sinuses - p. 999 146. Chapter 125: Angiomyomatous Hamartoma - p. 1003 147. Chapter 126: Palisaded Myofibroblastoma - p. 1007 148. Chapter 127: Metastatic Kaposi Sarcoma - p. 1011 149. INDEX - p. 1017
